Oncology Nursing News®
Oncology Nursing News CE
Current Issue
November/December 2019
View Past Issues
OncNurse TV
New Combos Are Coming to the Melanoma Space
New Combos Are Coming to the Melanoma Space
Nurses: Frequently Discuss AEs With Your Patients
Nurses: Frequently Discuss AEs With Your Patients
Monitor Toxicities When Treating Breast Cancer With Immunotherapy
Monitor Toxicities When Treating Breast Cancer With Immunotherapy
View more >>

Oncology Nursing Articles

FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma
FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma
BY KRISTIE L. KAHL
FDA Grants Fast Track Designation to Oncoprex Combination for NSCLC
FDA Grants Fast Track Designation to Oncoprex Combination for NSCLC
BY KRISTIE L. KAHL
Detecting and Managing irAEs in Melanoma Is Crucial
Detecting and Managing irAEs in Melanoma Is Crucial
BY BRITTANY COTE
Radiation's Role Shifts in Breast Cancer
Radiation's Role Shifts in Breast Cancer
BY JESSICA HERGERT
Deciding on Treatment for Metastatic Melanoma
Deciding on Treatment for Metastatic Melanoma
BY KRISTI ROSA
FDA Warns Against Potentially Contaminated Surgical Gowns
FDA Warns Against Potentially Contaminated Surgical Gowns
BY BRIELLE BENYON
FDA Grants Priority Review to Rucaparib for BRCA1/2-Positive mCRPC
FDA Grants Priority Review to Rucaparib for BRCA1/2-Positive mCRPC
BY KRISTIE L. KAHL
FDA Grants Priority Review to Frontline Nivolumab-Ipilimumab Combo for NSCLC
FDA Grants Priority Review to Frontline Nivolumab-Ipilimumab Combo for NSCLC
BY KRISTIE L. KAHL
Managing irAEs is a
Managing irAEs is a "Dynamic Discussion"
BY BRIELLE BENYON AND GINA COLUMBUS
Luspatercept Reduces Anemia in Patients With MDS
Luspatercept Reduces Anemia in Patients With MDS
BY BRITTANY COTE
The HER2+ Breast Cancer Landscape Continues to Change
The HER2+ Breast Cancer Landscape Continues to Change
BY ELLIE LEICK
FDA Grants Priority Review to Olaparib Plus Bevacizumab for Frontline Maintenance in Ovarian Cancer
FDA Grants Priority Review to Olaparib Plus Bevacizumab for Frontline Maintenance in Ovarian Cancer
BY GINA COLUMBUS
View more >>
Latest Contributor Articles
Strategic Alliance Partnership
We've partnered with leading institutions to bring you the most recent findings in the field of oncology. Click below for offerings from our partners
 
Latest Advocacy News
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.